Cargando…

Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer

Tumor-infiltrating lymphocytes (TILs) are a significant prognostic factor in triple-negative breast cancer. However, the clinicopathological significance of TILs in estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer remains unclear. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honda, Chikako, Kurozumi, Sasagu, Katayama, Ayaka, Hanna-Khalil, Bishoy, Masuda, Kei, Nakazawa, Yuko, Ogino, Misato, Obayashi, Sayaka, Yajima, Reina, Makiguchi, Takaya, Oyama, Tetsunari, Horiguchi, Jun, Shirabe, Ken, Fujii, Takaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521382/ https://www.ncbi.nlm.nih.gov/pubmed/34671471 http://dx.doi.org/10.3892/mco.2021.2414

Ejemplares similares

Oncological safety of immediate breast reconstruction with skin- or nipple-sparing mastectomy: the value of tumor-to-dermis distance measured by preoperative ultrasonography
por: Fujii, Takaaki, et al.
Publicado: (2021)

Phase II study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer
por: Yanai, Keiko, et al.
Publicado: (2020)

The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy
por: Nakazawa, Yuko, et al.
Publicado: (2020)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Clinicopathological values of PD-L1 expression in HER2-positive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer
por: Handa, Tadashi, et al.
Publicado: (2019)

Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2021)

Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2018)

ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab
por: Kurozumi, Sasagu, et al.
Publicado: (2015)

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
por: Kurozumi, Sasagu, et al.
Publicado: (2017)

Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients
por: Obayashi, Sayaka, et al.
Publicado: (2017)

Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
por: Hanamura, Toru, et al.
Publicado: (2023)

Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70‐interacting protein in postmenopausal breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2016)

Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
por: Hanamura, Toru, et al.
Publicado: (2023)

Fibrocystic breast disease with pleomorphic calcifications and segmental distribution: A case report
por: JiueLan, Kuo, et al.
Publicado: (2023)

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
por: Kurozumi, Sasagu, et al.
Publicado: (2016)

Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling
por: Horigome, Eisuke, et al.
Publicado: (2018)

Video-assisted thoracoscopic segmentectomy with combined chest wall resection: A case report
por: Ohtaki, Yoichi, et al.
Publicado: (2022)

Association of tumor size in pathological T4 colorectal cancer with desmoplastic reaction and prognosis
por: Shiraishi, Takuya, et al.
Publicado: (2022)

RNA‐sequence‐based microRNA expression signature in breast cancer: tumor‐suppressive miR‐101‐5p regulates molecular pathogenesis
por: Toda, Hiroko, et al.
Publicado: (2019)

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets
por: Kurozumi, Sasagu, et al.
Publicado: (2020)

Low level of stromal lectin‐like oxidized LDL receptor 1 and CD8 (+) cytotoxic T‐lymphocytes indicate poor prognosis of colorectal cancer
por: Katayama, Chika, et al.
Publicado: (2021)

Clinical and anatomical features of the lateral costal artery and vein
por: Nakazawa, Seshiru, et al.
Publicado: (2022)

Candida Costochondritis Induced by Traumatic Small Bowel Perforation: A Case Report
por: Nakamura, Hideharu, et al.
Publicado: (2023)

Surgical outcomes after multiple segmentectomy: a cohort study
por: Nakazawa, Seshiru, et al.
Publicado: (2022)

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
por: Katayama, Ayaka, et al.
Publicado: (2021)

Thoracoscopic S(4)a subsegmentectomy combined with wedge resections for treatment of metastatic tumors located at the intersection of the major and minor fissures
por: Obayashi, Kai, et al.
Publicado: (2020)

(18)F-fluorodeoxyglucose uptake as predictor for invasion in preoperatively diagnosed breast ductal carcinoma in situ: Significance in cases without mass formation
por: Fujii, Takaaki, et al.
Publicado: (2017)

Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis
por: Shiino, Sho, et al.
Publicado: (2021)

Comprehensive expressional analysis of chemosensitivity‐related markers in large cell neuroendocrine carcinoma of the lung
por: Ohtaki, Yoichi, et al.
Publicado: (2021)

Right upper lobe segmentectomy guided by simplified anatomic models
por: Nakazawa, Seshiru, et al.
Publicado: (2020)

Risk factors for late-onset pulmonary fistula after pulmonary segmentectomy
por: Kawatani, Natsuko, et al.
Publicado: (2023)

Clinicopathological features and surgical outcomes of lobectomy combined with segmentectomy: a cohort study
por: Nakazawa, Seshiru, et al.
Publicado: (2023)

A novel one-step lens cleaning device using air and water flow for endoscopic surgery
por: Tatsuki, Hironori, et al.
Publicado: (2018)

Elevation of soluble interleukin-2 receptor levels in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Cytoplasmic localization of connexin 26 suppresses transition of β‐catenin into the nucleus in intestinal‐ and mix‐type gastric cancer
por: Nakazawa, Nobuhiro, et al.
Publicado: (2022)

Fibro-osseous Pseudotumor of the Toe
por: Atomura, Daisuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_grq8ru6ihfgdcchr0pjodnmscd